(3S,3a'R,5a'S,9b'S)-3-(4-bromophenyl)-5a',9'-dimethyl-2-phenyl-3a',4',5',5a'-tetrahydro-2'H-spiro[isoxazolidine-5,3'-naphtho[1,2-b]furan]-2',8'(9b'H)-dione

ID: ALA2375835

PubChem CID: 73353361

Max Phase: Preclinical

Molecular Formula: C28H26BrNO4

Molecular Weight: 520.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1=C2[C@H]3OC(=O)C4(C[C@@H](c5ccc(Br)cc5)N(c5ccccc5)O4)[C@@H]3CC[C@@]2(C)C=CC1=O

Standard InChI:  InChI=1S/C28H26BrNO4/c1-17-23(31)13-15-27(2)14-12-21-25(24(17)27)33-26(32)28(21)16-22(18-8-10-19(29)11-9-18)30(34-28)20-6-4-3-5-7-20/h3-11,13,15,21-22,25H,12,14,16H2,1-2H3/t21-,22+,25+,27+,28?/m1/s1

Standard InChI Key:  AODICUCFAVBLJG-RDCCRBAQSA-N

Molfile:  

     RDKit          2D

 36 41  0  0  0  0  0  0  0  0999 V2000
   13.5366   -4.2114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1194   -4.7942    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8538   -4.4200    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7251   -3.6058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9109   -3.4771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0671   -2.8295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0671   -3.6537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7828   -4.0637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7828   -2.4111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4943   -2.8295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4958   -3.6537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9237   -2.8268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2067   -2.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3528   -4.0674    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.4872   -2.0011    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9253   -3.6510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2053   -4.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3748   -4.8738    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1970   -4.9659    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7824   -4.8920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6071   -5.6847    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6405   -3.2388    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   11.6220   -4.6491    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   15.1659   -2.9101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9906   -2.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4286   -2.2444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0431   -1.5151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2150   -1.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7808   -2.1852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5841   -4.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6257   -5.6154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3590   -5.9896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0514   -5.5409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0055   -4.7137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2718   -4.3430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4802   -0.8163    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  6  7  1  0
  6  9  2  0
  7  8  1  0
  8 11  2  0
 10  9  1  0
 10 11  1  0
 10 13  1  0
 11 17  1  0
 16 12  1  0
 12 13  1  0
  7 14  2  0
 10 15  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19  1  1  0
 16  1  1  0
  8 20  1  0
 19 21  2  0
 16 22  1  6
 17 23  1  1
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
  4 24  1  1
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 30  1  0
  3 30  1  0
 27 36  1  0
M  END

Associated Targets(Human)

RELA Tchem Nuclear factor NF-kappa-B p65 subunit (627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEp-2 (3859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 520.42Molecular Weight (Monoisotopic): 519.1045AlogP: 5.87#Rotatable Bonds: 2
Polar Surface Area: 55.84Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 6.35CX LogD: 6.35
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.46Np Likeness Score: 1.11

References

1. Khazir J, Singh PP, Reddy DM, Hyder I, Shafi S, Sawant SD, Chashoo G, Mahajan A, Alam MS, Saxena AK, Arvinda S, Gupta BD, Kumar HM..  (2013)  Synthesis and anticancer activity of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of α-santonin.,  63  [PMID:23501113] [10.1016/j.ejmech.2013.01.003]

Source